argenx SE (ARGX) Stock Forecast, Price Target & Predictions


OverviewOwnershipChartTranscripts

ARGX Stock Forecast


argenx SE (ARGX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $1,165.29, with a high of $1,415.00 and a low of $932.00. This represents a 16.26% increase from the last price of $1,002.31.

- $300 $600 $900 $1 $1 High: $1415 Avg: $1165.29 Low: $932 Last Closed Price: $1002.31

ARGX Stock Rating


argenx SE stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 1 Strong Buy (2.78%), 31 Buy (86.11%), 4 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 36 4 31 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks


TypeNameUpside
Stockargenx SE16.26%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends


1M3M12M
# Anlaysts102248
Avg Price Target$1.22K$1.13K$1.10K
Last Closing Price$1.00K$1.00K$1.00K
Upside/Downside21.29%13.22%9.78%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2612---3
Aug, 267142-124
Jul, 267153--25
Jun, 266153--24
May, 266153--24
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 31, 2026Morgan Stanley$1.25K$1.02K22.16%24.71%
Aug 26, 2026Derek ArchilaWells Fargo$1.42K$1.02K38.79%41.17%
Aug 26, 2026Xian DengUBS$1.40K$1.02K37.32%39.68%
Aug 18, 2026Morgan Stanley$1.23K$989.7924.27%22.72%
Aug 18, 2026Wedbush$1.15K$987.8416.42%14.73%
Aug 18, 2026Oppenheimer$1.10K$987.8411.35%9.75%
Aug 18, 2026Luca IssiRBC Capital$1.10K$987.8411.35%9.75%
Aug 18, 2026Danielle BrillTruist Financial$1.09K$987.8410.85%9.25%
Aug 18, 2026H.C. Wainwright$1.20K$987.8421.68%19.92%
Aug 17, 2026Piper Sandler$1.22K$851.2942.72%21.22%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Aug 26, 2026Wells FargoOverweightOverweighthold
Aug 26, 2026UBSNeutralBuyupgrade
Aug 24, 2026Deutsche BankBuyHolddowngrade
Aug 18, 2026Morgan StanleyOverweightOverweighthold
Aug 18, 2026WedbushOutperformOutperformhold
Aug 18, 2026OppenheimerOutperformOutperformhold
Aug 18, 2026RBC CapitalOutperformOutperformhold
Aug 18, 2026H.C. WainwrightBuyBuyhold
Aug 18, 2026CitigroupOutperformOutperformhold
Aug 18, 2026CitigroupMarket OutperformMarket Outperformhold

Financial Forecast


EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99$-13.05$-5.16-----
Avg Forecast$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Low Forecast$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Surprise %15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$497.28M$410.75M$1.23B-----
Avg Forecast$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Low Forecast$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Surprise %-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Low Forecast$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Surprise %3.06%309.90%10.05%-----

ARGX Forecast FAQ


Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 31 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 36 Wall Street analysts, averages $1.17K over the next 12 months. The price target range spans from $932 at the low end to $1.42K at the high end, suggesting a potential 16.26% change from the previous closing price of $1K.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 16.26% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • September 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 29.17% Strong Buy, 58.33% Buy, 8.33% Hold, 0% Sell, 4.17% Strong Sell.
  • July 2026: 28.00% Strong Buy, 60.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December 2024 is $2.19, marking a -142.44% decrease from the reported $-5.16 in 2023. Estimates for the following years are $9.99 in 2025, $18.54 in 2026, $26.94 in 2027, and $34.47 in 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December 2024 is $2.17B, reflecting a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, followed by $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

argenx SE's net income forecast for the fiscal year ending in December 2024 stands at $118.49M, representing a -140.16% decrease from the reported $-295M in 2023. Projections indicate $647.04M in 2025, $1.3B in 2026, $1.79B in 2027, and $1.97B in 2028.